Psoriasis


Case of the Month


Complimentary
CME/CE Activities




In The Headlines

Simberkoff MS, Arbeit RD, Johnson GR, et al.
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med. 2010 May 4;152(9):545-554.
View Abstract


Hurley LP, Lindley MC, Harpaz R, et al.
Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010 May 4;152(9):555-560.
View Abstract


Angel K, Provan SA,Gulseth HL, et al.
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension. 2010 Feb;55(2):333-338.
View Abstract


Griffiths CE, Strober BE, van de Kerhof P, et al.
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med. 2010 Jan 14;362(2):118-28.
View Abstract





Upcoming Conferences
AAD 2010
American Academy of Dermatology
Summer Academy Meeting
August 4-8, 2010
Chicago, IL
DNA 2010
DNA’s 29th Annual Convention
Summer Academy Meeting

March 17-20, 2011
San Diego, CA


Feedback Form
What would you like to see on this page?

 

 

Newsroom

In The Headlines

Simberkoff MS, Arbeit RD, Johnson GR, et al.
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med. 2010 May 4;152(9):545-554.
View Abstract


Hurley LP, Lindley MC, Harpaz R, et al.
Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010 May 4;152(9):555-560.
View Abstract


Angel K, Provan SA,Gulseth HL, et al.
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension. 2010 Feb;55(2):333-338.
View Abstract


Griffiths CE, Strober BE, van de Kerhof P, et al.
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med. 2010 Jan 14;362(2):118-28.
View Abstract


June 2010

Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H.
Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010 Jun;62(6):979-987.
View Abstract


March 2010

Pavelka K, Jarosova K, Suchy D, et al.
Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. Ann Rheum Dis 2009;68:1285-1289 doi:10. 1136/ard.2008.090860.
View Abstract


Mariette X, Tubach F, Bagheri H, et al.
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis 2010;69:400-408 doi:10.1136/ard.2009.117762.
View Abstract


Strangfeld A, Listing J, Herzer P, et al.
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009 Feb 18;301(7):737-744.
View Abstract


Burmester GR, Mease P, Dijkmans BA, et al.
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis. 2009 Dec;68(12):1863-1869. Epub 2009 Jan 15.
View Abstract


Kay J, Westhovens R
Methotrexate: the gold standard without standardisation. Ann Rheum Dis 2009;68:1081-1082 doi: 10. 1136/ard.2008. 102822.
View Abstract


Copyright © 2007-2010. All Rights Reserved | Privacy Policy | Terms of Use